Deep Longevity launches Accrua telehealth platform in US
Deep Longevity will launch Accrua, a consumer digital health and telehealth platform, in the United States in October 2026 and make the service available across all 50 US states. The platform centers on the company’s AI-generated BloodAge report, which uses a routine blood test to estimate biologica
<p>Deep Longevity will launch Accrua, a consumer digital health and telehealth platform, in the United States in October 2026 and make the service available across all 50 US states. The platform centers on the company’s AI-generated BloodAge report, which uses a routine blood test to estimate biologica</p>